Pieris Pharmaceuticals
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
225 Franklin St Fl 26, Boston, Massachus...Phone Number
(857) 246-8998Website
www.pieris.comRevenue
$40.9 MillionStock Symbol
PIRSIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Pieris Pharmaceuticals
Founded in 2000 and headquartered in Boston, Massachusetts, Pieris Pharmaceuticals is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs. The company is headquartered in Boston, Massachusetts.Explore more
Pieris Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
JB
Manager, Financial Analysis
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pieris Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Pieris Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on Pieris Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Pieris Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Pieris Pharmaceuticals
Check if Pieris Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if Pieris Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Pieris Pharmaceuticals has new funding data
Pieris Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Pieris Pharmaceuticals
Compare insights from companies similar to Pieris Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pieris Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Pieris Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Pieris Pharmaceuticals.
Pieris Pharmaceuticals Tech Stack
A closer look at the technologies used by Pieris Pharmaceuticals
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Event
presented three proposals for stockholder action at its annual meeting: election of two directors to serve until 2027, ratification of Ernst & Young LLP as auditors for 2024, and approval of named executive officer compensation on a non-binding advisory basis.
Compensation & Benefits, Audit, Internal Audit & Control, Corporate Strategy, Finance, Governance, HR Operations, Operations
Event
closed the polls for its 2024 stockholder meeting at 9:03 p.m. Preliminary voting results showed a plurality of votes in favor of electing nominated directors, and a majority of votes to ratify Ernst & Young LLP as auditors and approve named executive officer compensation.
Compensation & Benefits, Audit, Internal Audit & Control, Corporate Strategy, Finance, Governance, HR Operations, Operations
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Earnings
Pieris Pharmaceuticals News & Media
PIERIS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pieris Pharmaceuticals, Inc. - PIRS
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Pieris Pharmaceuticals, Inc. (NasdaqCM: PIRS) (the “Company”) and Palvella Therapeutics, Inc. Upon completion of the proposed transaction, Pieris shareholders are expected to own approximately 18% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequPIRS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pieris Pharmaceuticals, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) and Palvella Therapeutics, Inc. is fair to Pieris shareholders. Pre-merger Pieris shareholders are expected to own approximately 18% of the combined company. Halper Sadeh encourages Pieris shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halperALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Pieris Pharmaceuticals, Inc.
NEW YORK, July 24, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) and its board of directors concerning the proposed acquisition of the company by Palvella Therapeutics, Inc. Pieris Pharmaceuticals...PIRS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pieris Pharmaceuticals, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) and Palvella Therapeutics, Inc. is fair to Pieris shareholders. Pre-merger Pieris shareholders are expected to own approximately 18% of the combined company. Halper Sadeh encourages Pieris shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halper
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Pieris Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Founded in 2000 and headquartered in Boston, Massachusetts, Pieris Pharmaceuticals is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs. The company is headquartered in Boston, Massachusetts.... Read More
